Web31 mar 2024 · Scientific Articles Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial WebJCOG1007: Japan: UMIN000008147: 0S, 3 yrs: 770 → 280: Jun 12: Dec 20: Recruiting * SYNCHRONOUS and CCRe-IV trails are ongoing and participants are receiving an intervention or being examined, but potential participants are …
Essential Readings in Surgical Oncology (shared collection)
Webincurable stage IV colorectal cancer: JCOG1007 (iPACS study). Jpn J Clin Oncol 2024;50:89-93. 13. Kim CW, Baek JH, Choi GS, Yu CS, Kang SB, Park WC, et al. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: study proto-col for a randomized controlled trial. Trials … Web6 dic 2024 · Primary tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial trick fabrication
A randomized controlled trial comparing primary tumour …
WebA randomized phase III trial comparing primary tumor resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 study (iPACS). … Web24 nov 2024 · Kanemitsu Y, Shitara K, Mizusawa J, et al. Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial. J Clin Oncol. 2024:JCO2002447. WebA randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study) Konosuke Moritani , Yukihide Kanemitsu , Dai Shida , Kohei Shitara , Junki Mizusawa ... term of business